2-203936873-G-A
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_012092.4(ICOS):c.58+1G>A variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.0000189 in 1,425,698 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_012092.4 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ICOS | NM_012092.4 | c.58+1G>A | splice_donor_variant, intron_variant | Intron 1 of 4 | ENST00000316386.11 | NP_036224.1 | ||
ICOS | XR_007073112.1 | n.110+1G>A | splice_donor_variant, intron_variant | Intron 1 of 5 | ||||
LOC101927840 | XR_427213.4 | n.314+444C>T | intron_variant | Intron 2 of 3 | ||||
ICOS | XM_047444022.1 | c.-3562G>A | upstream_gene_variant | XP_047299978.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ICOS | ENST00000316386.11 | c.58+1G>A | splice_donor_variant, intron_variant | Intron 1 of 4 | 1 | NM_012092.4 | ENSP00000319476.6 | |||
ICOS | ENST00000435193.1 | c.58+1G>A | splice_donor_variant, intron_variant | Intron 1 of 3 | 1 | ENSP00000415951.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000399 AC: 1AN: 250398Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135492
GnomAD4 exome AF: 0.0000189 AC: 27AN: 1425698Hom.: 0 Cov.: 25 AF XY: 0.0000225 AC XY: 16AN XY: 711698
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Immunodeficiency, common variable, 1 Pathogenic:1
This sequence change affects a donor splice site in intron 1 of the ICOS gene. It is expected to disrupt RNA splicing and likely results in an absent or disrupted protein product. This variant is present in population databases (rs757598952, ExAC 0.002%). This variant has not been reported in the literature in individuals with ICOS-related disease. Donor and acceptor splice site variants typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in ICOS are known to be pathogenic (PMID: 11343122, 12577056, 19380800). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Inherited Immunodeficiency Diseases Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at